Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Empagliflozin (Jardiance®) receives SMC approval for treatment of heart failure

October 13, 2021 Research and Development

The Scottish Medicines Consortium (SMC) has announced that empagliflozin (Jardiance®) has been accepted for use by NHS Scotland, for the …
News
moderna_norwood_plant

Gavi to purchase 176.5 million doses of Moderna COVID-19 vaccine for low income countries

October 13, 2021 Research and Development

COVAX has purchased more than 210 million doses of their vaccine for delivery to low income countries. This supply agreement …
News
pfizer

Pfizer enlists entire town in Brazil for COVID study

October 7, 2021 Research and Development

An entire town in Brazil has been enrolled by Pfizer to study the transmission of the coronavirus within a vaccinated …
News

WHO rolls out GSK’s malaria vaccine in Africa

October 7, 2021 Medical Communications, Research and Development

The WHO has given the go-ahead for the mass roll out of a malaria vaccine for children, in a historic …
News

Janssen’s bowel disease drug shown to be safe for use in older patients

October 6, 2021 Research and Development

The Janssen Pharmaceutical Companies of J&J have announced that STELARA® (ustekinumab) has a high safety profile in older patients across …
News

UroGen Pharma shows positive results for bladder cancer patients

October 6, 2021 Research and Development

UroGen Pharma Ltd has published results from the Phase IIb OPTIMA II trial, a single-arm trial studying UGN-102 (mitomycin) as …
News

Third dose of COVID-19 vaccine approved for immunocompromised over 12

October 6, 2021 Research and Development

The EMA have authorised the third dose of the Moderna COVID-19 vaccine (Spikevax), to be administered on immunocompromised individuals aged …
News

Merck secures Singapore deal for COVID antiviral pill

October 6, 2021 Medical Communications, Research and Development

Merck announced on Wednesday a supply and purchase agreement that will provide Singapore with access to its experimental oral COVID-19 …
News

Bayer wins first court case in Roundup child cancer battle

October 6, 2021 Medical Communications, Research and Development

Bayer AG has won its first court case over claims its Roundup weed killer causes cancer after a California jury …
News

Brain implant can lift severe depression, study finds

October 5, 2021 Manufacturing and Production, Research and Development

Researchers from the University of California have created an electrical implant that sits in the skull, wired to the brain, …
News

NICE recommends first new sickle cell disease treatment in 20 years

October 5, 2021 Manufacturing and Production, Medical Communications, Research and Development

NICE has announced on Tuesday that for the first time in 20 years, a new treatment will be made available …
News
az

FDA grants BTD for Daiichi Sankyo and AstraZeneca’s Enhertu

October 4, 2021 Research and Development, Sales and Marketing

AstraZeneca and Daiichi Sankyo have today announced that the FDA has granted Enhertu (fam-trastuzumab deruxtecan-nxki) breakthrough therapy designation (BTD) for …
News

Avacta reaches milestone in LG Chem partnership

September 29, 2021 Research and Development

Clinical stage biopharmaceutical company, Avacta Group plc, has announced that a preclinical development milestone has been achieved in the partnership …
News
39736431593_abc529f43d_c

Novartis autoinjector effective for treating psoriasis

September 29, 2021 Research and Development

New data show that Novartis Cosentyx (secukinumab) 300-mg single dose autoinjector resulted in high efficacy vs placebo. Cosentyx is a …
News
white-shutterstock_71287333

Acacia Pharma’s new cancer care injection approved in Europe

September 29, 2021 Research and Development

Biopharmaceutical company Acacia Pharma Group plc (Acacia Pharma) has announced that its Marketing Authorisation Application (MAA) for BARHEMSYS® (amisulpride injection) …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026